References
- FerlayJShinHRBrayFFormanDMathersCParkinDMEstimates of worldwide burden of cancer in 2008: GLOBOCAN 2008Int J Cancer2010127122893291721351269
- HeidenreichAAusGBollaMEAU guidelines on prostate cancerEur Urol20085316880 Available from: https://www.ncbi.nlm.nih.gov/pubmed/?term=17920184Accessed June 22, 201717920184
- PallweinLMitterbergerMPelzerAUltrasound of prostate cancer: recent advancesEur Radiol200818470771517938936
- SankhwarMSankhwarSNAbhishekARajenderSClinical significance of the VEGF level in urinary bladder carcinomaCancer Biomark201515434935525792473
- MontironiRSantoniMSotteVEmerging Immunotargets and Immunotherapies in Prostate CancerCurr Drug Targets201617777778226898309
- LeclercBGCharleboisRChouinardGCD73 Expression Is an Independent Prognostic Factor in Prostate CancerClin Cancer Res201622115816626253870
- CollisonLWWorkmanCJKuoTTThe inhibitory cytokine IL-35 contributes to regulatory T-cell functionNature2007450716956656918033300
- DevergneOBirkenbachMKieffEEpstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietinProc Natl Acad Sci USA1997942212041120469342359
- NiedbalaWWeiXQCaiBIL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cellsEur J Immunol200737113021302917874423
- CollisonLWChaturvediVHendersonALIL-35-mediated induction of a potent regulatory T cell populationNat Immunol201011121093110120953201
- WangRXYuCRDambuzaIMInterleukin-35 induces regulatory B cells that suppress autoimmune diseaseNat Med201420663364124743305
- LiXMaiJVirtueAIL-35 is a novel responsive anti-inflammatory cytokine – a new system of categorizing anti-inflammatory cytokinesPLoS One201273e3362822438968
- LongJZhangXWenMIL-35 over-expression increases apoptosis sensitivity and suppresses cell growth in human cancer cellsBiochem Biophys Res Commun2013430136436923154182
- MaoHGaoWMaCHuman placental trophoblasts express the immunosuppressive cytokine IL-35Hum Immunol201374787287723619469
- LiyanageUKMooreTTJooHGPrevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinomaJ Immunol200216952756276112193750
- NishinoRTakanoAOshitaHIdentification of Epstein-Barr virus-induced gene 3 as a novel serum and tissue biomarker and a therapeutic target for lung cancerClin Cancer Res201117196272628621849417
- WangZLiuJQLiuZTumor-derived IL-35 promotes tumor growth by enhancing myeloid cell accumulation and angiogenesisJ Immunol201319052415242323345334
- OlsonBMJankowska-GanEBeckerJTVignaliDABurlinghamWJMcNeelDGHuman prostate tumor antigen-specific CD8+ regulatory T cells are inhibited by CTLA-4 or IL-35 blockadeJ Immunol2012189125590560123152566
- LiuYWuYWangYIL-35 mitigates murine acute graft-versus-host disease with retention of graft-versus-leukemia effectsLeukemia201529493994625363669
- OlsonBMSullivanJABurlinghamWJInterleukin 35: a key mediator of suppression and the propagation of infectious toleranceFront Immunol2013431524151492
- NiedobitekGPazoltDTeichmannMDevergneOFrequent expression of the Epstein-Barr virus (EBV)-induced gene, EBI3, an IL-12 p40-related cytokine, in Hodgkin and Reed-Sternberg cellsJ Pathol2002198331031612375263
- PoleganovMABachmannMPfeilschifterJMuhlHGenome-wide analysis displays marked induction of EBI3/IL-27B in IL-18-activated AML-derived KG1 cells: critical role of two kappaB binding sites in the human EBI3 promotorMol Immunol200845102869288018336908
- TurnisMESawantDVSzymczak-WorkmanALInterleukin-35 Limits Anti-Tumor ImmunityImmunity201644231632926872697
- ZhangYSunHWuHTanQXiangKInterleukin 35 is an independent prognostic factor and a therapeutic target for nasopharyngeal carcinomaContemp Oncol (Pozn)201519212012426034389
- JinPRenHSunWXinWZhangHHaoJCirculating IL-35 in pancreatic ductal adenocarcinoma patientsHum Immunol2014751293324121041
- ZengJCZhangZLiTYAssessing the role of IL-35 in colorectal cancer progression and prognosisInt J Clin Exp Pathol2013691806181624040445
- GuXTianTZhangBElevated plasma interleukin-35 levels predict poor prognosis in patients with non-small cell lung cancerTumour Biol20153642651265625480413